Results 81 to 90 of about 1,506 (115)

Management of thyroid disorders: from autoimmunity to malignancy - novel insights from precision medicine: <i>How to manage thyroid diseases: from autoimmunity to malignancy</i> Special Issue. [PDF]

Drugs Context
Saltiki K, Effraimidis G.
europepmc   +1 more source

RET Signaling Pathway in Human Cancer: Oncogenic Mechanisms, Selective Inhibitors, and Emerging Resistance Strategies. [PDF]

Int J Mol Sci
Streit S, Dweik A, Mahtab A, Ali S, Khan A, Salzberg M.   +5 more
europepmc   +1 more source

<i>FGFR3-TACC3</i> fusion as a potential primary resistance mechanism to EGFR-TKI in lung adenocarcinoma harboring co-driven mutations: a case report. [PDF]

Front Oncol
Wang X, Qiu L, Liang J, Liu F, Ma X, Yang P.   +5 more
europepmc   +1 more source

RET-driven osteoprotegerin expression links medullary thyroid cancer to osteoblastic bone metastases. [PDF]

Cell Rep Med
Bagheri-Yarmand R, Pagnotti GM, Kidd JL, Ramirez DA, Trupti Trivedi, Guerra L, Wang Z, Cruz LM, Moehle JM, Jebaraj YS, Wan X, Song JH, Bassett RL, Lin SH, Hu MI, Sherman SI, Hofmann MC, Guise TA.   +17 more
europepmc   +1 more source

Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma. [PDF]

Cancer Lett
Hinz TK, Le AT, Doan T, Ast A, Jaramillo S, Avila JT, Skhisov D, Haines S, Navarro AC, Patil T, Nemenoff RA, Heasley LE.   +11 more
europepmc   +1 more source

Mechanism of and research progress on alterations in the RET gene in thyroid cancer (Review). [PDF]

Mol Med Rep
Wei M, Wang R, Qian J, Fang Q, Tao J.
europepmc   +1 more source

Real-world evidence of RET fusion prevalence and testing in patients with metastatic non-small cell lung cancer. [PDF]

Transl Oncol
Garcia BNC, de Jager VD, Epskamp-Kuijpers CCHJ, van der Wekken AJ, Willems SM, van Kempen LC, Schuuring E.   +6 more
europepmc   +1 more source

Matching-adjusted indirect comparison of selpercatinib and pralsetinib in <i>RET</i> fusion-positive non-small cell lung cancer. [PDF]

Future Oncol
Hochmair M, Kiiskinen U, D'yachkova Y, Puri T, Wang X, Wolowacz S, Vickers A, Nadal E.   +7 more
europepmc   +1 more source

How to manage radioiodine-refractory thyroid cancer in the era of precision medicine. [PDF]

Drugs Context
Karapanou O, Effraimidis G, Michalaki M, Saltiki K.   +3 more
europepmc   +1 more source